PNMAL1 was suggested as a potential prognostic biomarker of human PDAC (pancreatic ductal adenocarcinoma), since elevated expression was significantly associated with better overall survival [108]. The gene discussed is PNMA8A; the disease is pancreatic ductal adenocarcinoma.